Verus Capital Partners’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
VCM
VPM
Verus Capital Partners's JNJ Position: Q1 2026 in Review
Verus Capital Partners reduced its Johnson & Johnson (JNJ) stake by 2% in Q1 2026, selling an estimated $34.2K and leaving 7,335 shares worth $1.79M. The position accounts for 0.12% of the portfolio, ranked #115.
Verus Capital Partners first reported a position in JNJ in Q4 2019 and has held it in 19 quarters since. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- Verus Capital Partners held 7,335 shares of Johnson & Johnson worth $1.79M as of Q1 2026.
- Verus Capital Partners sold 147 Johnson & Johnson shares in Q1 2026, an estimated $34.2K.
- Johnson & Johnson made up 0.12% of Verus Capital Partners's portfolio in Q1 2026, its #115 holding.
- Verus Capital Partners first reported a position in Johnson & Johnson in Q4 2019 and has held it in 19 quarters since.
- 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on Verus Capital Partners's 13F filing for Q1 2026, filed 22 May 2026.